Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Baltimore, Maryland


Purpose:

This study will determine if a highly selective enkephalinergic receptor modulator is effective in the treatment of anxious major depressive disorder.


Criteria:

Inclusion Criteria: - Provision of informed consent prior to any study specific procedures Exclusion Criteria: - A history of substance or alcohol abuse within the past 6 months or dependence within 1 year of enrollment as defined by DSM-IV criteria. - Women that are pregnant or lactating - History of pancreatitis


NCT ID:

NCT00759395


Primary Contact:

Study Director
Mark Smith, MD
AstraZeneca


Backup Contact:

N/A


Location Contact:

Baltimore, Maryland
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.